Previous 10 | Next 10 |
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will release its financial results for the second quarter and six months ended June 30, 2023, after the close of market on Wednesday, Aug. 2, 2023. Com...
Castle employees to raise funds and awareness for five partner organizations in support of patients impacted by skin cancer, esophageal cancer, mental health conditions and uveal melanoma Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that g...
Castle also earns national recognition through five Top Workplaces Culture Excellence Awards — Innovation, Work-Life Flexibility, Compensation & Benefits, Leadership and Purpose & Values Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovativ...
2023-07-13 17:18:16 ET Shares of Castle Biosciences (NASDAQ: CSTL) were down more than 20.2% for the week as of Thursday's close, according to data provided by S&P Global Market Intelligence . The healthcare stock closed last week at $20.30, then fell to as low as $15.55...
2023-07-11 16:45:41 ET Summary Castle Biosciences makes tests for patients diagnosed with certain diseases to help evaluate optimal treatment options. The company's lead products are its DecisionDx tests for melanoma and SCC patients. Castle's share price plunged when it looke...
2023-07-07 12:50:55 ET Gainers: Prestige Wealth ( PWM ) +90% . Castle Biosciences ( CSTL ) +52% . Near Intelligence ( NIR ) +44% . T2 Biosystems ( TTOO ) +37% . Greenidge Generation Holdings ( GREE ) +31% . The Real Good Food...
2023-07-07 12:16:19 ET Castle Biosciences (NASDAQ: CSTL) stock was absolutely crushing it on Friday, with shares skyrocketing 54.4% as of 11:47 a.m. ET. The huge gain came after Novitas, a regional Medicare administrative contractor, said that it is withdrawing a draft policy that w...
2023-07-07 10:45:34 ET Update 10:45 AM EST: Adds comments from Craig Hallum Diagnostics firm Castle Biosciences ( NASDAQ: CSTL ) added ~41% in the morning hours Friday in a move attributed to an unexpected policy reversal regarding Medicare coverage for the company’s ...
2023-07-07 10:07:00 ET Gainers: Castle Biosciences ( CSTL ) +43% . CareDx ( CDNA ) +20% . COMPASS Pathways ( CMPS ) +9% . TG Therapeutics ( TGTX ) +9% . KalVista Pharmaceuticals ( KALV ) +8% . Losers: PainReform ( P...
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, will present new data on its gene expression profile (GEP) risk-stratification test for patients with cutaneous squamous cell carcinoma (SCC), DecisionDx®-SCC, and its GEP ri...
News, Short Squeeze, Breakout and More Instantly...
Castle Biosciences Inc. Company Name:
CSTL Stock Symbol:
NASDAQ Market:
Castle Biosciences Inc. Website:
Campaign will focus on empowering patients impacted by melanoma Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, has joined forces with television personality, wellness coach and founder of ALL IN by Teddi, host of the...
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will release its financial results for the second quarter and six months ended June 30, 2024, after the close of market on Monday, Aug. 5, 2024. Compan...
Castle earns recognition as an Arizona Top Workplace, a national Healthcare Industry Top Workplace and receives five Top Workplaces Culture Excellence Awards Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today annou...